Cutler Group LLC / CA - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 44 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Cutler Group LLC / CA ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$1,000
-85.7%
600
-73.9%
0.00%
Q3 2021$7,000
-22.2%
2,3000.0%0.00%
Q2 2021$9,0000.0%2,300
-4.2%
0.00%
Q1 2021$9,000
-30.8%
2,400
-50.4%
0.00%
-100.0%
Q4 2020$13,0000.0%4,8400.0%0.00%0.0%
Q3 2020$13,000
-7.1%
4,840
-72.2%
0.00%0.0%
Q2 2020$14,000
+16.7%
17,400
+324.4%
0.00%0.0%
Q1 2020$12,000
-68.4%
4,100
-48.1%
0.00%
-66.7%
Q4 2019$38,000
+31.0%
7,900
+11.3%
0.00%0.0%
Q3 2019$29,000
-70.7%
7,100
-36.0%
0.00%
-66.7%
Q2 2019$99,000
+175.0%
11,100
+56.3%
0.01%
+200.0%
Q1 2019$36,000
-20.0%
7,100
-59.6%
0.00%
-40.0%
Q4 2018$45,000
-80.6%
17,561
-56.6%
0.01%
-68.8%
Q3 2018$232,000
+70.6%
40,422
+84.9%
0.02%
+60.0%
Q2 2018$136,000
-16.0%
21,861
-39.1%
0.01%
-23.1%
Q1 2018$162,000
-18.6%
35,907
-54.0%
0.01%
+44.4%
Q4 2017$199,000
+37.2%
78,000
-8.1%
0.01%
+50.0%
Q3 2017$145,000
-56.6%
84,900
-55.7%
0.01%
-53.8%
Q2 2017$334,000
-78.1%
191,438
-27.3%
0.01%
-79.7%
Q1 2017$1,525,000
+27.8%
263,400
+21.4%
0.06%
+48.8%
Q4 2016$1,193,000
+1047.1%
217,000
+222.9%
0.04%
+760.0%
Q3 2016$104,00067,2000.01%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Beryl Capital Management LLC 4,898,927$6,246,1320.70%
Yakira Capital Management, Inc. 620,019$790,5240.22%
Crystalline Management Inc. 230,817$294,2920.21%
DELTEC ASSET MANAGEMENT LLC 475,000$605,6250.14%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 2,283,979$2,912,0730.12%
PenderFund Capital Management Ltd. 123,444$2130.06%
FIFTH LANE CAPITAL, LP 100,000$127,0000.04%
CSS LLC/IL 476,831$607,9600.04%
Penserra Capital Management LLC 220,858$2800.01%
King Wealth Management Group 16,000$200.00%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders